Cryopreserved Platelets (CPP) for US FDA Licensure

Location: Maryland
Posted: Apr 28, 2026
Due: May 4, 2026
Agency: DEPT OF DEFENSE
Type of Government: Federal
Category:
  • A - Research and development
Solicitation No: HT9427-26-RFI-705
Publication URL: To access bid details, please log in.
Follow
Cryopreserved Platelets (CPP) for US FDA Licensure
Active
Contract Opportunity
Notice ID
HT9427-26-RFI-705
Related Notice
Department/Ind. Agency
DEPT OF DEFENSE
Sub-tier
DEFENSE HEALTH AGENCY (DHA)
Office
ARMY MED RES ACQ ACTIVITY
Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information View Changes
  • Contract Opportunity Type: Sources Sought (Updated)
  • Updated Published Date: Apr 28, 2026 09:17 am EDT
  • Original Published Date: Apr 23, 2026 12:47 pm EDT
  • Updated Response Date: May 04, 2026 03:00 pm EDT
  • Original Response Date: May 04, 2026 03:00 pm EDT
  • Inactive Policy: 15 days after response date
  • Updated Inactive Date: May 19, 2026
  • Original Inactive Date: May 19, 2026
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code:
  • NAICS Code:
    • 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
  • Place of Performance:
    Frederick , MD 21702
    USA
Description

Defense Health Agency seeks to develop and manage medical materiel to protect and sustain the Warfighter on point for the Nation. We develop, directly through collaboration with commercial partners, medical products that enhance readiness and improve the quality of life of active-duty personnel in the operational environment. OPMED’s WPAC PMO has been developing a biologic product: Dimethyl Sulfoxide (DMSO) Cryopreserved Platelets (CPP), a frozen, biologic-platelet product. DMSO CPP are formulated to provide a platelet-derived product with a longer shelf life (2 years and potentially longer) than liquid stored platelets (LSP), which are currently licensed for storage up to 5-7 days at room temperature (20ºC to 24ºC) under gentle agitation.


Attachments/Links
Contact Information
Contracting Office Address
  • 808 SCHREIDER ST
  • FORT DETRICK , MD 21702
  • USA
Primary Point of Contact
Secondary Point of Contact
History

Related Document

Apr 23, 2026[Sources Sought (Original)] Cryopreserved Platelets (CPP) for US FDA Licensure
Daily notification on new contract opportunities

With GovernmentContracts, you can:

  • Find more opportunities and win more business
  • Receive daily alerts for all new bid opportunities
  • Get contract opportunities matched to your business
ONE WEEK FREE TRIAL

See also

...) Place of Performance: Frederick , MD USA Description The Medical Technology Enterprise ...

DEPT OF DEFENSE

Bid Due: 7/01/2026

...Follow Medical Support Assistant (MSA) Support Services Active Contract Opportunity Notice ID 26...: ...

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Bid Due: 6/04/2026

...3 NAVY MEDICINE WEST Office NAVAL MEDICAL RESEARCH CENTER Looking for contract opportunity ...

DEPT OF DEFENSE

Bid Due: 12/31/2026

..., system calibration, and corrective repairs require factory-trained personnel with direct access... provided ...

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Bid Due: 6/11/2026

* Disclaimer: Information regarding bids, requests for proposals (RFPs), or requests for qualifications (RFQs) is provided on this website only for convenience and does not constitute official public notice. Persons wishing to respond to or inquire about bids, RFPs, or RFQs should contact the appropriate government department.